Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Specimen Handling 271Magnetic Resonance Spectroscopy 222pembrolizumab 216Carboplatin 175Biopsy 166Cisplatin 155Nivolumab 150Cyclophosphamide 135Paclitaxel 120Radiotherapy 117Gemcitabine 111Bevacizumab 93durvalumab 85Dexamethasone 83Rituximab 76Oxaliplatin 71atezolizumab 70Doxorubicin 67Capecitabine 67Fluorouracil 66venetoclax 65Etoposide 64Docetaxel 64Radiosurgery 58Radiation 57Cytarabine 57Prednisone 56Pemetrexed 55Ipilimumab 55Lenalidomide 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Ciprofloxacin × 90 days × Clear all
NCT06728072 2026-05-06

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Virginia Commonwealth University

Phase 2 Recruiting
97 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡